Company Overview: Verona Pharmaceuticals specializes in treatments for respiratory diseases. The company recently received FDA approval for its inhaled non-steroidal COPD treatment, Ohtuvayre. Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is a leading cause of death. Key Highlights: FDA Approval: Ohtuvayre has...
VRNA stock run up is way overdone. Leave it to scumbag analysts to upgrade a stock only after a major run up where are these douchebags when the stocks are cheap? Pump n dump much? Purchased a total of 70 puts so far will add for each $1 share price increase until correction
VRNA overbought on positive lung cancer results. These money losing pharma stocks always tend to overshoot. We should correct under $15 in coming days. Purchased 50 Feb 17th $20 puts. Will add for each $1 increase in share price.
I found this pattern at tickeron website with the following data: STATUS = Confirmed CURRENT CONFIDENCE = 84% TARGET (EXIT) PRICE = 3.84 USD BREAKOUT (ENTRY) PRICE = 6.60 USD DISTANCE TO TARGET PRICE = 39.95% EMERGED ON = Aug 19, 12:00 PM (EDT) CONFIRMED ON = Sep 03, 01:03 PM (EDT) WITH CONFIDENCE LEVEL = 98% The Three Falling Peaks pattern forms when three minor...